[Preservatives in ophthalmology]
- PMID: 23179809
- DOI: 10.1007/s00347-012-2638-4
[Preservatives in ophthalmology]
Abstract
Preservatives are a legal requirement for eye drops in multidose containers. Moreover, they are necessary for stabilization and intraocular penetration for a number of ophthalmic preparations. Most preservatives act in a relatively unspecific manner as detergents or by oxidative mechanisms and thereby cause side effects at the ocular surface. They may also affect the lens, trabecular meshwork and the retina. Benzalkonium chloride is the most commonly used preservative in ophthalmology and is more toxic than other or newer preservatives, such as polyquaternium-1 (Polyquad), sodium perborate, oxychloro-complex (Purite®) and SofZia. Preservative-free topical medication is highly recommended for patients with ocular surface disease, frequent eye drop administration, proven allergy to preservatives and contact lens wear.
Similar articles
-
Ocular preservatives: associated risks and newer options.Cutan Ocul Toxicol. 2009;28(3):93-103. doi: 10.1080/15569520902995834. Cutan Ocul Toxicol. 2009. PMID: 19505226 Review.
-
[A correct understanding of preservatives in eye drops].Zhonghua Yan Ke Za Zhi. 2015 Sep;51(9):641-4. Zhonghua Yan Ke Za Zhi. 2015. PMID: 26693647 Chinese.
-
Preservatives and ocular surface disease: A review.Ocul Surf. 2024 Oct;34:213-224. doi: 10.1016/j.jtos.2024.08.001. Epub 2024 Aug 3. Ocul Surf. 2024. PMID: 39098762 Review.
-
Ophthalmic preservatives: focus on polyquaternium-1.Expert Opin Drug Deliv. 2011 Nov;8(11):1425-38. doi: 10.1517/17425247.2011.617736. Epub 2011 Sep 9. Expert Opin Drug Deliv. 2011. PMID: 21905766 Review.
-
Anaphylaxis with use of eye-drops containing benzalkonium chloride preservative.Clin Exp Optom. 2009 Sep;92(5):444-6. doi: 10.1111/j.1444-0938.2009.00395.x. Epub 2009 Jun 22. Clin Exp Optom. 2009. PMID: 19549228 No abstract available.
Cited by
-
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease--A Prospective, Multicenter Noninterventional Study.J Ocul Pharmacol Ther. 2015 Oct;31(8):498-503. doi: 10.1089/jop.2015.0048. Epub 2015 Aug 21. J Ocul Pharmacol Ther. 2015. PMID: 26296040 Free PMC article.
-
The pathophysiology, diagnosis, and treatment of dry eye disease.Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82. doi: 10.3238/arztebl.2015.0071. Dtsch Arztebl Int. 2015. PMID: 25686388 Free PMC article. Review.
-
A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives.Pharmaceutics. 2023 Mar 19;15(3):990. doi: 10.3390/pharmaceutics15030990. Pharmaceutics. 2023. PMID: 36986851 Free PMC article. Review.
-
Ocular surface alterations and topical antiglaucomatous therapy: a review.Open Ophthalmol J. 2014 Oct 3;8:67-72. doi: 10.2174/1874364101408010067. eCollection 2014. Open Ophthalmol J. 2014. PMID: 25317218 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical